Anti-B12 molecules have been synthesized with an “upper” axial substituent, that is inert to the Cbl-reducing enzyme methylmalonic aciduria and homocystinuria type C protein (CblC) [17, 24, 25]. This evidence concerns the gene CBLC and Methylmalonic aciduria.